Glass syringes will lead syringe filling machine sales through 2036 with 62.0% share of the syringe type segment in 2026, driven by superior chemical compatibility and sterility performance for biologics and vaccines. The market was valued at USD 443.4 million in 2025 and is expected to be worth USD 697.17 million by 2036.